Storyline
Eli Lilly Zepbound obesity drug FDA approval and rollout
One page that accretes the verified record as the story develops. Every fact keeps its date and its sources.
96 DAYS
0 FACTS
6 EVENTS
0 SOURCES
FIRST ENTRY NOV 08
FEB 11 · Day 96
Ozempic and Mounjaro success drives biopharma obesity drug arms race
FEB 09 · Day 94
Ozempic and weight loss drugs tied to lower depression and anxiety risk
FEB 06 · Day 91
Eli Lilly earnings beat estimates on strong Zepbound and Mounjaro sales
JAN 04 · Day 58
Eli Lilly launches direct sales and home delivery of weight-loss drug Zepbound
NOV 28 · Day 21
Eli Lilly weight-loss drug beats Novo Nordisk in head-to-head study
NOV 08 · Day 1